Literature DB >> 2328392

Vasopressin and stress-induced antinociception in the mouse.

S L Hart1, A O Oluyomi.   

Abstract

1. Arginine vasopressin produced antinociception in the hot-plate test after intracerebroventricular injection (0.5 micrograms) and in the acetic acid abdominal constriction test after intraperitoneal injection (0.1 mg kg-1). 2. The antinociception produced by arginine vasopressin was sensitive to deamino(CH2)5Tyr(Me) arginine vasopressin (0.5 micrograms i.c.v.; 0.1 mg kg-1 i.p.) but not to naloxone (5 micrograms i.c.v.; 2 mg kg-1 i.p.) 3. Arginine vasopressin when administered by the intracerebroventricular route, but not by the intraperitoneal route, produced characteristic behaviour which was sensitive to deamino(CH2)5Tyr(Me) arginine vasopressin (0.5 micrograms, i.c.v.). 4. A 3 min swim at 20 degrees C produced antinociception on the hot-plate which was sensitive to naloxone (0.4 mg kg-1, i.p.) but not to deamino(CH2)5Tyr(Me) arginine vasopressin (0.5 micrograms, i.c.v.). 5. The reduction in the number of acetic acid-induced abdominal constrictions produced by a 30 s swim at 30 degrees C was not sensitive to either naloxone (2 mg kg-1, i.p.) or deamino(CH2)5Tyr(Me) arginine vasopressin (0.1 mg kg-1, i.p.). 6. Arginine vasopressin, at high doses, is antinociceptive in the mouse but does not appear to mediate stress-induced antinociception in this species.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2328392      PMCID: PMC1917363          DOI: 10.1111/j.1476-5381.1990.tb14688.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  17 in total

1.  Role of spinal cord neuropeptides in pain sensitivity and analgesia: thyrotropin releasing hormone and vasopressin.

Authors:  L R Watkins; S N Suberg; C L Thurston; E S Culhane
Journal:  Brain Res       Date:  1986-01-08       Impact factor: 3.252

Review 2.  Saturable transport of peptides across the blood-brain barrier.

Authors:  W A Banks; A J Kastin
Journal:  Life Sci       Date:  1987-09-14       Impact factor: 5.037

3.  The involvement of opioid delta-receptors in stress induced antinociception in mice.

Authors:  S L Hart; H Slusarczyk; T W Smith
Journal:  Eur J Pharmacol       Date:  1983-11-25       Impact factor: 4.432

4.  Possible physiological control of morphine analgesia in mice.

Authors:  F C Tulunay; M F Jen; H H Loh
Journal:  Eur J Pharmacol       Date:  1982-09-24       Impact factor: 4.432

5.  Dynorphin immunoreactivity in pituitary.

Authors:  B M Cox; E R Baer; A Goldstein
Journal:  Adv Biochem Psychopharmacol       Date:  1982

6.  The effects of selective opioid delta-receptor antagonists on stress-induced antinociception and plasma corticosterone levels in mice.

Authors:  S L Hart; H Slusarczyk; T W Smith
Journal:  Neuropeptides       Date:  1985-02       Impact factor: 3.286

7.  The role of endorphins in stress-induced analgesia.

Authors:  D D Kelly
Journal:  Ann N Y Acad Sci       Date:  1982       Impact factor: 5.691

8.  Vasopressin-induced antinociception: an investigation into its physiological and hormonal basis.

Authors:  B S Berson; G G Berntson; W Zipf; M W Torello; W T Kirk
Journal:  Endocrinology       Date:  1983-07       Impact factor: 4.736

9.  Vasopressin and oxytocin in the rat spinal cord: analysis of their role in the control of nociception.

Authors:  M J Millan; C Schmauss; M H Millan; A Herz
Journal:  Brain Res       Date:  1984-09-10       Impact factor: 3.252

10.  Central antinociceptive effects of lysine-vasopressin and an analogue.

Authors:  J H Kordower; V Sikorszky; R J Bodnar
Journal:  Peptides       Date:  1982 Jul-Aug       Impact factor: 3.750

View more
  1 in total

1.  Birth elicits a conserved neuroendocrine response with implications for perinatal osmoregulation and neuronal cell death.

Authors:  Yarely C Hoffiz; Alexandra Castillo-Ruiz; Megan A L Hall; Taylor A Hite; Jennifer M Gray; Carla D Cisternas; Laura R Cortes; Andrew J Jacobs; Nancy G Forger
Journal:  Sci Rep       Date:  2021-01-27       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.